Press Releases
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
Clinical device expected availability in 2026 Scalable platform launch planned for 2027 [ MIAMI ] — KIFFIK Biomedical Inc. (“KIFFIK”), a leader in interstitial fluid (ISF)-based diagnostics, today announced a strategic manufacturing partnership with Beacon MedTech Solutions to deliver its K-EXP™ platform. The K-EXP™ clinical device is expected to be...
The K-EXP™ platform enables direct access to interstitial fluid for molecular measurement at the source Partnership supports regulatory, clinical, and commercial expansion across Japan and Asia-Pacific [ MIAMI, FL AND TOKYO, JAPAN / ACCESS Newswire ] – KIFFIK Biomedical today announced a strategic alliance with HekaBio K.K. to expand access...
Building the Foundation for the Next Generation of Biological Measurement